Deanna Strable
Analyst · KBW. Please proceed with your question
Thanks, Dan. Good morning to everyone on the call. This morning, I’ll share the key contributors to our financial performance for the quarter and full year, updates on our investment portfolio, our current capital position, as well as details of our outlook for 2024. Full year reported net income was $623 million. Excluding exited business, net income was $1.5 billion for the full year with credit losses of $81 million. Fourth quarter net income, excluding exited business was $299 million with $27 million of credit losses. As a reminder, the income from exited business is non-economic and is driven by the change in the fair value of the funds withheld embedded derivative. It doesn’t impact our capital or free cash flow and can be extremely volatile quarter-to-quarter. Full year credit drift and losses were modest and better than our expectations at the beginning of the year. Excluding significant variances, full year non-GAAP operating earnings was $1.7 billion or $6.92 per diluted share. This was a 6% increase in EPS over 2022 at the top end of our 3% to 6% outlook and included $436 million in the fourth quarter or $1.81 per diluted share. As detailed on slide 24, significant variances impacted fourth quarter non-GAAP operating earnings by a net positive $5 million on both a pre-tax and after-tax basis and $0.02 per diluted share. The significant variances included strong encaje performance largely offset by lower variable investment income. Looking at macroeconomics in the fourth quarter, the S&P 500 daily average was slightly higher than the third quarter of 2023 and 16% higher than the fourth quarter of 2022. While the S&P 500 Index increased 24% from the end of 22, the daily average increased just 4% from the 2022 daily average. In addition, the S&P 500 performed better than mid-cap, small-cap and international equities, as well as fixed income and alternatives. Relative to our 2023 outlook, the daily average increase was lower than our typical 6% price appreciation assumption, but it was higher than expected heading into the year. Foreign exchange rates were a headwind relative to the third quarter, but a tailwind compared to the fourth quarter of 2022 and on a trailing 12-month basis. Margins across the enterprise remained strong as we took actions to reduce expenses to align with revenue, while investing for growth and increasing scalability. On a full year basis, compensation and other expenses increased modestly over 2022 despite elevated severance expense of $20 million in the fourth quarter and $30 million for the full year. Turning to the business units, the following comments exclude significant variances and demonstrate our ability to meet or exceed most of our 2023 guidance ranges. Starting with RIS, fourth quarter pre-tax operating earnings were very strong and increased 22% over the fourth quarter of 2022 driven by growth in the business and strong revenue retention, higher net investment income and favorable markets. Full year net revenue growth of 4% and the 39% margin were at the high end of our guided ranges. Our focus on profitable revenue growth is paying off and was aided by favorable macroeconomic impacts. PGI’s pre-tax margin of 35% for the full year was within our guided range, a strong result compared to many of our peers, reflecting disciplined expense management, while navigating a pressured revenue environment. PGI’s full year revenue growth was slightly below our guided range given the market volatility, as well as the industry trend of money moving to money market funds in 2023. At $34 million for the full year, performance fees ended the year in line with our outlook despite a pressured real estate market. This compares to a very strong year in 2022, which had $70 million. Performance fees are dependent on market conditions as to when we can optimize alpha generation in the portfolio. Principal International ended the year strong with full year revenue growth of 9%, a 32% margin and an 11% increase in pre-tax operating earnings over 2022. Results benefited from growth in the business, higher AUM, positive net cash flow and foreign currency tailwinds. Both revenue growth and margin were within our guided ranges. Specialty Benefits continued to deliver in 2023 with a 9% growth in premium and fees, a 15% margin and a 17% increase in pre-tax operating earnings compared to full year 2022. This was fueled by another year of record sales, strong retention and employment and wage growth, as well as a more favorable loss ratio. All of our metrics for specialty benefits were within our guided ranges. In Life, growth in premium and fees was within our guided range as our focus on business solutions is outpacing the roll-off of the legacy block. Margin was slightly below our guided range primarily due to lower net investment income as we right-sized the assets backing the business post-transaction. Shifting to our investment portfolio, it remains high quality, aligned with our liability profile and well-positioned for a variety of economic conditions. We revalued the office real estate portfolio again in the fourth quarter as we have done quarterly throughout 2023. The commercial mortgage loan portfolio remains healthy. The average loan-to-value of 49% increased modestly throughout 2023, as we expected while the debt service coverage ratio remained stable at 2.5 times, reflecting the quality of our portfolio and our disciplined investment approach. Specific to our office exposure in the CML portfolio, there were 10 loans that matured in 2023, reducing our office loan exposure by 12%. All loans were paid off and resolved. We did not have any loan extensions or foreclosures in 2023. Looking at the 2024 office maturities, the underlying metrics are generally strong, with an average loan-to-value of 66% and debt service coverage ratio of 3.8 times. We only have one maturity in the first quarter and it paid off in January. We’re actively managing and remain confident in the outcome of the remaining 10 maturities, eight of which are slated for the second half of the year. Turning to capital and liquidity, we ended the year in a very strong position, with $1.7 billion of excess and available capital, including approximately $935 million at the holding company, which is above our $800 million targeted level, $375 million in our subsidiaries and $375 million in excess of our targeted 400% risk-based capital ratio, which was 427% at the end of the year. Our capital position and free cash flow reflect robust fourth quarter results and actions we took to increase capital efficiency, including the establishment of an affiliated Bermuda reinsurance entity and the closure of certain guaranteed retirement products in Hong Kong. Combined, these actions freed up more than $200 million of capital in the fourth quarter. On a full year basis, we delivered 100% free capital flow conversion, including organic generation within our 75% to 85% targeted range. As shown on slide three, we returned $1.3 billion to shareholders in 2023, including $700 million of share repurchases and $625 million of common stock dividends. This included more than $400 million of capital returned to shareholders in the fourth quarter, with approximately $250 million of share repurchases and $160 million of common stock dividends. Last night we announced a $0.69 common stock dividend payable in the first quarter, a $0.02 increase from the dividend paid in the fourth quarter and in line with our targeted 40% dividend payout ratio. This demonstrates our confidence in continued growth and overall performance. We remain focused on maintaining our capital and liquidity targets at both the life company and the holding company, and will continue a balanced and disciplined approach to capital deployment. Turning to our outlook for 2024, starting on slide 13, we are well positioned to deliver on our enterprise long-term financial targets in 2024, with 9% to 12% growth in earnings per share and 75% to 85% free capital flow conversion. In regards to EPS, benefits from growth in the business, favorable macroeconomic tailwinds and higher share repurchases are expected to more than offset continued pressure on real estate, Asia and a higher effective tax rate. Our higher growth, higher return and more capital efficient portfolio will continue to drive an increase in return on equity and we expect to achieve our 14% to 16% targeted range in 2025. We remain committed to returning excess capital to shareholders and are targeting $1.5 billion to $1.8 billion of capital deployments in 2024. This includes $800 million to $1.1 billion of share repurchases and a 40% dividend payout ratio. Our Board of Directors approved a new share repurchase authorization for $1.5 billion. This is in addition to nearly $300 million remaining under the prior authorization at the end of the year. Our guidance assumes run rate variable investment income. As usual, we’ll quantify the impacts to reported results from higher or lower than expected variable investment income as a significant variance on our earnings calls throughout the year. Slide 21 provides details of our alternative investments. Our portfolio is more heavily weighted to real estate, with a smaller allocation to private equity and hedge funds. Variable investment income is difficult to predict, but if the current macro environment persists throughout 2024, we expect continued pressure on prepayment fees and real estate returns. Turning to our business units, our outlook for 2024 is grounded in our long-term guidance. We included some modeling considerations on slide 14, noting where we expect to perform on an adjusted basis relative to our targeted long-term ranges. In RIS, benefits from macroeconomic tailwinds and growth in the business are expected to drive revenue growth at the high end or slightly above our long-term guidance, and margin at the upper end of our range. In PGI, revenue growth is expected to be at the lower end of our long-term guidance, as benefits from market tailwinds are partially offset by continued pressure on real estate revenue and impacts from recent redemptions. In Principal International, margin is expected to be in line with 2023 and we’re expecting low single-digit revenue growth, reflecting the impact of foreign currency translation and continued macro headwinds in Asia. While the closure of the guaranteed retirement products will impact revenue and earnings in Asia, Latin America is expected to continue to deliver strong earnings growth. In benefits and protection, we expect favorable loss ratios and Specialty Benefits to persist in 2024 and expect to be toward the lower half of our long-term range. The margin for Life Insurance is expected to be slightly below the long-term range but improve from 2023. Before opening for questions, I want to remind you of a few seasonality impacts. In PGI, the first quarter is typically our lowest quarter for earnings due to the seasonality of deferred compensation and elevated payroll taxes. And in Specialty Benefits, dental claims are typically higher in the first half of the year. These factors contribute to the pattern of free capital flow, which is typically lightest in the first quarter and increases throughout the year. We have good momentum as we start 2024 with a strong capital position and we are well positioned to deliver on our long-term financial targets. We are grounded in our growth drivers of retirement, asset management, and benefits and protection and executing on a strategy focused on continuing to drive long-term shareholder value. This concludes our prepared remarks. Operator, please open the call for questions.